Benefiting from technological and conceptual groundwork and positive early data, gene therapies are advancing in the clinic ...

Women may be missing a diagnosis of a potentially deadly heart condition due to guidelines that don't account for natural differences in sex and body size.

Women may be missing a diagnosis of a potentially deadly heart condition due to guidelines that don't account for natural differences in sex and body size, according to a new study led by UCL ...

After the successful development of mavacamten and the sale of MyoKardia to BMS in 2020, former executives of the biotech are ...

Trametinib, a mitogen-activated protein kinase (MEK) inhibitor, reduces mortality and morbidity in children with severe ...

Women are missing out on crucial cardiac diagnoses due to outdated guidelines aimed at men, a study suggests. Research by the ...

The findings show that, over a three-year period, children who received the standard treatment alone had an 80-per-cent ...

Study warns of risks of intense training in young athletes: when does exercise benefit or harm children's hearts?

Women may be missing a diagnosis of a potentially deadly heart condition due to guidelines that don't account for natural ...

Trametinib, a mitogen-activated protein kinase (MEK) inhibitor, reduces mortality and morbidity in children with severe hypertrophic cardiomyopathy (HCM) caused by pathogenic variants in the RAS/MAPK ...